.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Doxercalciferol - Generic Drug Details

« Back to Dashboard
Doxercalciferol is the generic ingredient in two branded drugs marketed by Hikma Pharms Llc, Rising Pharms Inc, Sandoz Inc, Genzyme Corp, Akorn Inc, and Roxane, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for doxercalciferol. Seven suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for Generic Name: doxercalciferol

Tradenames:2
Patents:0
Applicants:6
NDAs:8
Drug Master File Entries: see list9
Suppliers / Packaging: see list7
Therapeutic Class:Metabolic Bone Disease Agents
Drug Prices:see low prices

Pharmacology for Ingredient: doxercalciferol

Ingredient-typeErgocalciferols
Drug ClassVitamin D2 Analog

Tentative approvals for DOXERCALCIFEROL

Applicant Application No. Form Dosage
<disabled><disabled>INJECTABLE; INJECTION2MCG/ML

Clinical Trials for: doxercalciferol

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Rising Pharms Inc
DOXERCALCIFEROL
doxercalciferol
CAPSULE;ORAL201518-001Sep 9, 2016RXNo
Genzyme Corp
HECTOROL
doxercalciferol
CAPSULE;ORAL020862-003Jul 13, 2009RXNo
Sandoz Inc
DOXERCALCIFEROL
doxercalciferol
INJECTABLE;INJECTION091333-001May 5, 2014RXNo
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: doxercalciferol

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Genzyme Corp
HECTOROL
doxercalciferol
CAPSULE;ORAL020862-001Jun 9, 19995,602,116<disabled>
Genzyme Corp
HECTOROL
doxercalciferol
INJECTABLE;INJECTION021027-001Apr 6, 20005,602,116<disabled>
Genzyme Corp
HECTOROL
doxercalciferol
INJECTABLE;INJECTION021027-001Apr 6, 20005,707,980<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc